1. Synthesis, stereochemistry and antimicrobial studies of novel oxime ethers of aza/diazabicycles
- Author
-
Paramasivam Parthiban, Paramasivam Rathika, Venkatachalam Ramkumar, Gopalakrishnan Aridoss, and Senthamaraikannan Kabilan
- Subjects
Antifungal Agents ,Klebsiella pneumoniae ,Clinical Biochemistry ,Pharmaceutical Science ,Aspergillus flavus ,Biochemistry ,chemistry.chemical_compound ,antibacterial activity ,Drug Discovery ,Candida albicans ,Oximes ,Bicyclo Compounds ,Antibacterial agent ,Candida ,biology ,Bicyclic molecule ,stereochemistry ,Antimicrobial ,Oxime ,amphotericin B ,Anti-Bacterial Agents ,antiinfective agent ,Pseudomonas aeruginosa ,Molecular Medicine ,Aspergillus niger ,Rhizopus ,Ethers ,crystal structure ,Staphylococcus aureus ,in vitro study ,Stereochemistry ,Bridged Bicyclo Compounds ,oxime derivative ,ciprofloxacin ,Escherichia coli ,controlled study ,drug screening ,drug inhibition ,Molecular Biology ,nuclear magnetic resonance spectroscopy ,antimicrobial activity ,nonhuman ,Bacteria ,Organic Chemistry ,antifungal activity ,Fungi ,Salmonella typhi ,biology.organism_classification ,dilution ,chemistry ,drug synthesis - Abstract
Two series of bicyclic oxime ethers viz, 2,4-diaryl-3-azabicyclo[3.3.1]nonan-9-one O-benzyloximes 13-24 and 2,4,6,8-tetraaryl-3,7-diazabicyclo[3.3.1]nonan-9-one O-benzyloximes 31-36 were synthesized and stereochemistry was established by their spectral (1D and 2D NMR) and crystal studies. Synthesized oxime ethers were screened for their in vitro antimicrobial activity against a set of pathogenic bacteria (Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella typhi, Escherichia coli and Klebsiella pneumoniae) and fungi (Candida albicans, Candida-51, Rhizopus sp., Aspergillus niger and Aspergillus flavus) by twofold serial dilution method, respectively, using Ciprofloxacin and Amphotericin B as standards. Most of the molecules expressed promising antimicrobial profile against the tested pathogens and even a few compounds 16, 21, 22, 33 and 34 were better than standard drugs. � 2009 Elsevier Ltd. All rights reserved.
- Published
- 2009